AI Integration for Intelerad Neurology

AI integration for Intelerad Neurology connects at three primary workflow surfaces: the PowerReader workstation, the Workflow Manager API, and the Reporting module. For neurology-specific studies—such as brain MRI for MS lesion burden, CT perfusion for stroke, or volumetric analysis for dementia—AI models are triggered via DICOM Modality Worklist or a post-storage commitment hook. The AI service, typically a containerized inference engine, receives the study via DICOMweb, processes it for tasks like automated lesion segmentation, large vessel occlusion (LVO) detection, or hippocampal volumetry, and returns structured results as DICOM Structured Reports (SR) or annotations (GSPS). These AI outputs are then embedded back into the study series within the Intelerad VNA, making them immediately available for the neuroradiologist's review.

The critical integration nuance is ensuring AI results are contextually presented without disrupting the radiologist's hanging protocol. For example, a stroke AI detection for LVO can automatically prioritize the study on the emergency worklist via the Workflow Manager API and present a color-coded overlay on the MIP reconstruction within PowerReader. For quantitative workflows, like MS follow-up, the AI-generated lesion count and volume can be auto-populated into a structured report template, saving the clinician from manual segmentation and measurement. This requires precise mapping between AI output fields (e.g., "lesion_volume_cc": 4.7) and the report template's data points, often facilitated by a lightweight middleware service that translates DICOM SR to HL7 FHIR observations for the reporting engine.

Rollout and governance for this integration follow a phased, service-line approach. A typical pilot starts with a single, high-impact use case—like non-contrast CT hemorrhage detection for stroke alert—integrated into the ED radiology workflow. This allows validation of the AI performance, the alerting mechanism (e.g., via Intelerad's notification system or a downstream HL7 ADT message to the stroke team), and the radiologist's feedback loop. Governance focuses on audit trails (logging every AI inference, its input hash, and result), human-in-the-loop verification (the radiologist must confirm or reject the AI finding before final sign-off), and continuous monitoring for model drift against the health system's patient population. Successful deployment hinges on treating the AI not as a replacement, but as a prioritization and quantification copilot, integrated so seamlessly that it reduces click burden and accelerates time-to-treatment for neurological emergencies.

Integration begins at the worklist level, where incoming DICOM studies for neurology (brain MRI, CT, perfusion) are automatically routed. Using Intelerad's Workflow Manager APIs or a DICOM router, studies matching neurology-specific modalities and body parts are flagged. A secure, de-identified copy of the relevant series is sent via DICOMweb or a RESTful API to a containerized AI inference service. This service runs algorithms for tasks like acute hemorrhage detection, large vessel occlusion (LVO) identification, or quantitative brain volumetry for dementia tracking. The results are packaged as a DICOM Structured Report (SR) or a JSON payload containing measurements, segmentations, and confidence scores.

The AI outputs are then injected back into the Intelerad ecosystem. For critical findings like a suspected LVO, the SR can trigger an HL7 ORU message to create an alert in the radiologist's worklist, prioritizing the case. For quantitative analysis, the data is stored as private DICOM tags or linked annotations, making them accessible within the PowerReader workstation. Here, the neuroradiologist sees AI-generated segmentations overlaid on the source images, automated measurements populated in report macros, and a findings suggestion panel integrated beside the reporting interface. This creates a seamless, human-in-the-loop review where the clinician verifies, adjusts, and finalizes the AI-assisted report.

Governance and rollout require a phased approach. Start with a silent mode where AI runs in the background without affecting the worklist, allowing performance validation against historical reports. For production, implement role-based access controls (RBAC) within Intelerad to determine which users see AI prompts. Establish an audit trail logging every AI inference, user interaction, and report modification for quality assurance and regulatory compliance. For enterprise scale, deploy the AI services on a Kubernetes cluster adjacent to your Intelerad Cloud or on-premises VNA, using service meshes for secure, reliable communication between PACS and inference engines. This architecture ensures AI augments the diagnostic pathway without disrupting the core clinical workflow. For broader context on enterprise imaging AI strategy, see our guide on AI Integration for Enterprise Imaging AI.

Integrating AI into a neurology PACS like Intelerad requires a security-first architecture that respects the clinical data lifecycle. This means establishing a zero-trust data pipeline where DICOM studies are securely routed from the Intelerad VNA or PowerReader workstation to a dedicated, HIPAA-compliant inference service. AI results—typically as DICOM Structured Reports (SR) or annotations—are then injected back into the study as a secondary capture or linked finding, preserving the original images and creating a full audit trail. Access to AI tools and results is controlled via the same role-based access controls (RBAC) governing the PACS, ensuring only authorized neurologists and neuroradiologists can view or act upon AI-generated insights.

A successful rollout follows a phased, risk-managed approach. Phase 1 often begins with a non-diagnostic, quantitative AI tool—such as automated brain volumetry for dementia tracking—deployed in a single clinic or research setting. This allows validation of the integration's technical reliability and clinician workflow without impacting high-acuity decisions. Phase 2 introduces detection AI (e.g., for large vessel occlusion in stroke) into a controlled, human-in-the-loop workflow where the AI acts as a prioritization agent, flagging potential critical cases at the top of the worklist without auto-populating reports. Each phase includes defined key performance indicators (KPIs) like time-to-notification reduction, radiologist agreement rates, and system uptime, measured against a baseline.

Governance is maintained through a continuous feedback loop. All AI interactions are logged, capturing the original study, the AI inference input/output, the reviewing clinician, and any overrides or confirmations. This traceability is critical for algorithmic drift monitoring, clinical validation, and regulatory compliance. A cross-functional AI Steering Committee—with representation from neurology, IT, compliance, and administration—should review these logs and KPIs quarterly to approve progression to the next phase, adjust workflows, or retire underperforming models. This structured, incremental path de-risks adoption and builds the organizational trust necessary to scale AI from a pilot to a production neurology decision-support layer across the enterprise.